(PharmaNewsWire.Com, May 31, 2019 ) According to the new market research report "Medical Tapes and Bandages Market by Product (Tapes (Fabric, Paper, Plastic), Bandage (Gauze, Adhesive, Cohesive & Elastic)), Application (Surgery, Trauma & Laceration, Ulcer, Sport, Burns), End User (Hospitals, ASCS, Clinics, Homecare) - Forecast to 2022", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Don’t miss out on business opportunities in Medical Tapes and Bandages Market.
This report studies the global medical tapes and medical bandages market over the forecast period of 2017 to 2022. This market is projected to reach USD 7.39 Billion by 2022 from USD 6.13 Billion in 2017, at a CAGR of 3.8%. Factors such as rising number of surgeries, increasing incidence of chronic wounds, and rising geriatric population are driving the growth of the market.
This research study involves the extensive use of secondary sources, directories, and databases (such as Hoover’s, Bloomberg Business, Factiva, and Avention), to identify and collect information useful for this technical, market-oriented, and financial study of the medical bandages market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.
Browse and in-depth TOC on "Medical Tapes and Bandages Market"
This report broadly segments the medical tapes and bandages market into product type, end user, application, and region. By product type, the market is categorized into medical tapes and bandages. In 2016, the medical bandages segment accounted for the largest share of the market. This can be attributed to the high number of surgical procedures, increasing aging population, and a rise in medical conditions which require surgical intervention.
By applications, the market is segmented into surgical treatment, traumatic & laceration injury treatment, sport & burn injury treatment, ulcer treatment, and treatment of other injuries and wounds. The ulcer treatments segment is expected to grow at the fastest rate during the forecast period, due to the rising number of patients with ulcers due to growth in the diabetic population.
Based on end users, the market is categorized into hospitals, clinics, ambulatory surgical centers, and homecare setting. The hospitals segment accounted for the major share of the market in 2016, owing to many surgical procedures performed in hospitals.
This report covers the market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, Asia-Pacific is expected to register the highest growth rate during the forecast period mainly due to rising an aging and diabetes-prone population.
Key Players
The major players in the market include 3M Company (U.S.), Medtronic plc (Ireland), Johnson & Johnson Consumer Inc. (U.S.), Medline Industries, Inc. (U.S.), BSN Medical (Germany), Cardinal Health, Inc. (U.S.), Beiersdorf (Germany), Nitto Denko Corporation (Japan) Nichiban Co., Ltd. (Japan), Lohmann & Rauscher (Germany), Derma Sciences Inc. (U.S.), Smith & Nephew (U.K.), B Braun Melsungen AG (Germany), PAUL HARTMANN AG (Germany), Mölnlycke Health Care (Sweden), Andover Healthcare Inc. (U.S.), Dukal Corporation (U.S.), Dynarex Corporation (U.S.), AVCOR Health Care Products, Inc (U.S.), Tetra Medical Supply Corporation (U. S.), Kerma Medical Products Inc. (U.S.), and DermaRite Industries, LLC. (U.S.).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
